Cotinga Pharmaceuticals Inc.
Cotinga Pharmaceuticals Inc. (COTQF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cotqf · pe ratio · data through Apr 30, 2019
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Cotinga Pharmaceuticals Inc. (COTQF) measures how much investors pay for each dollar of the company's trailing earnings. COTQF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.09.
Source: FMP · /ratios-ttm · /analyst-estimates · 2019-04-30
PE Ratio History
2013 – 2019 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Cotinga Pharmaceuticals Inc.You COTQF | $0M | N/A | — | -$0.09 |
 Anthera Pharmaceuticals, Inc. ANTH | $0M | N/A | — | -$1.65 |
 Dermisonics, Inc. DMSI | $0M | N/A | — | -$0.12 |
 Fiore Cannabis Ltd. FIORF | $0M | N/A | — | -$0.06 |
 ForU Holdings, Inc. FORU | $0M | N/A | — | -$8.27 |
 iBX Group, Inc. IBXG | $0M | N/A | — | — |
 9 Meters Biopharma, Inc. NMTRQ | $0M | N/A | — | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2019-04-30Latest FY2019 | — | $-0.09 | — | |
2018-04-30 FY2018 | — | $-0.24 | — | |
2017-04-30 FY2017 | — | $-0.31 | — | |
2016-04-30 FY2016 | — | $-0.31 | — | |
2015-04-30 FY2015 | — | $-0.29 | — | |
2014-04-30 FY2014 | — | $-0.31 | — | |
2013-04-30 FY2013 | — | $-0.35 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Cotinga Pharmaceuticals Inc. (COTQF) measures how much investors pay for each dollar of the company's trailing earnings. COTQF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.09.
Frequently asked questions
COTQF pe ratio · 6 questionsCOTQF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.09. Data sourced from Financial Modeling Prep via COTQF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Cotinga Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09